Kenneth Gruber (IMAGE)
Caption
Gruber is close to entering clinical trials for a drug that could delay a horrible side effect of cancer and give doctors additional time and treatment options for their patients.
Credit
Nathan Hurst/University of Missouri
Usage Restrictions
None
License
Licensed content